Genetic sequence variant (GSV) in TERT-CLPTM1L (5p15.33 locus) and survival in platinum-treated stage-IV non-small cell lung cancer (NSCLC)

被引:0
|
作者
Azad, Abul Kalam
Qiu, Xiaoping
Cuffe, Sinead
Qiu, Xin
Boyd, Kevin
Kuang, Qin
Emami, Marjan
Perera, Nicole
Palepu, Prakruthi R.
Patel, Devalben
Chen, Zhuo
Cheng, Dangxiao
Feld, Ronald
Leighl, Natasha B.
Shepherd, Frances A.
Tsao, Ming Sound
Xu, Wei
Liu, Geoffrey
机构
[1] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada
[2] Wuhan Univ, Sch Med, Wuhan, Hubei, Peoples R China
[3] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
[4] Univ Toronto, Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1535
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy
    Zhang, Ruoxin
    Jia, Ming
    Xue, Huijing
    Xu, Yuan
    Wang, Mengyun
    Zhu, Meiling
    Sun, Menghong
    Chang, Jianhua
    Wei, Qingyi
    SCIENTIFIC REPORTS, 2017, 7
  • [22] Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy
    Ruoxin Zhang
    Ming Jia
    Huijing Xue
    Yuan Xu
    Mengyun Wang
    Meiling Zhu
    Menghong Sun
    Jianhua Chang
    Qingyi Wei
    Scientific Reports, 7
  • [23] Survival outcome segregated by KRAS mutation status in newly diagnosed stage IV non-small cell lung cancer (NSCLC) patients (pts) treated with first-line chemotherapy
    Brady, Anna K.
    McNeill, Jonathan D.
    Judy, Brendan
    Evans, Tracey L.
    Cohen, Roger B.
    Langer, Corey J.
    Vachani, Anil
    Aggarwal, Charu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] The P38α rs3804451 Variant Predicts Chemotherapy Response and Survival of Patients with Non-Small Cell Lung Cancer Treated with Platinum-Based Chemotherapy
    Jia, Ming
    Xu, Yuan
    Zhu, Meiling
    Wang, Mengyun
    Sun, Menghong
    Qian, Ji
    Chang, Jianhua
    Wei, Qingyi
    TRANSLATIONAL ONCOLOGY, 2016, 9 (06): : 531 - 539
  • [25] ERCC1 Expression Does Not Predict Survival and Treatment Response in Advanced Stage Non-Small Cell Lung Cancer Cases Treated with Platinum Based Chemotherapy
    Ozdemir, Ozer
    Ozdemir, Pelin
    Veral, Ali
    Uluer, Hatice
    Ozhan, Mustafa Hikmet
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (08) : 4679 - 4683
  • [26] Mitotic checkpoint gene CHFR methylation in pretreatment serum DNA of docetaxel (doc)/cisplatin (cis)-treated stage IV non-small cell lung cancer (NSCLC) patients (p).
    Isla, D.
    Salazar, F.
    Ramirez, J.
    Ronco, M. Sanchez
    Cobo, M.
    Montes, A.
    Sanchez, J.
    Catot, S.
    Taron, M.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 378S - 378S
  • [27] Elevated levels of thioredoxin (Trx) in serum correlate with poor outcome in docetaxel (doc)/cisplatin (cis)-treated stage IV non-small cell lung cancer (NSCLC) patients (p)
    Molina, M.
    Camps, C.
    de las Penas, R.
    Alonso, G.
    Lopez-Vivanco, G.
    Provencio, M.
    Gonzalez-Larriba, J.
    Salazar, F.
    Sanchez, J.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR. 24 trial of platinum-treated advanced stage non-small cell lung cancer patients
    Cuffe, Sinead
    Azad, Abul Kalam
    Qiu, Xiaoping
    Qiu, Xin
    Brhane, Yonathan
    Kuang, Qin
    Marsh, Sharon
    Savas, Sevtap
    Chen, Zhuo
    Cheng, Dangxiao
    Leighl, Natasha B.
    Goss, Glenwood
    Laurie, Scott A.
    Seymour, Lesley
    Bradbury, Penelope A.
    Shepherd, Frances A.
    Tsao, Ming Sound
    Chen, Bingshu E.
    Xu, Wei
    Liu, Geoffrey
    CANCER EPIDEMIOLOGY, 2016, 41 : 50 - 56
  • [29] The effect of PD-L1 status on survival outcomes in patients with stage II-III non-small cell lung cancer treated with chemotherapy
    Karaca, Mustafa
    Tural, Deniz
    Akar, Emre
    Unal, Damla
    Bayraktaoglu, Mesut
    Akyurek, Nalan
    Ozet, Ahmet
    JOURNAL OF BUON, 2020, 25 (01): : 268 - 273
  • [30] ENLARGE Lung: Observational data on overall survival, safety and quality of life of 882 patients with locally advanced or metastatic (stage IIIB/IV) non-small cell lung cancer (NSCLC) treated with nivolumab in Germany
    Schumann, C.
    Groeschel, A.
    Guetz, S.
    Schulz, H.
    Mueller-Huesmann, H.
    Liersch, R.
    von der Heyde, E.
    Waldenberger, D.
    Sebastian, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 150 - 150